Gautam J et al. |
An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. |
2016 |
J. Pharm. Pharmacol. |
pmid:27265669
|
Maser RE et al. |
Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. |
2016 |
J. Diabetes Complicat. |
pmid:26775555
|
Bernardi S et al. |
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. |
2016 |
Biomed Res Int |
pmid:27200369
|
Sasso GR et al. |
Elevated serum osteoprotegerin levels in women: friend or foe? |
2015 Nov-Dec |
Rev Assoc Med Bras (1992) |
pmid:26841162
|
Calasans-Maia MD et al. |
Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814461
|
Jianru YI et al. |
Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814456
|
SaÄŸlam M et al. |
Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. |
2015 Jan-Feb |
J Appl Oral Sci |
pmid:25760266
|
Esteghamati A et al. |
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. |
2015 Aug-Sep |
Arch Cardiovasc Dis |
pmid:26184866
|
Ren H et al. |
Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. |
2015 |
Mol Med Rep |
pmid:26398911
|
Schmitz F et al. |
Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. |
2015 |
Cell Metab. |
pmid:26094892
|